Linguamatics NLP for Electronic Health Records
|
|
- Meryl Watson
- 5 years ago
- Views:
Transcription
1 1 Linguamatics 2013 Linguamatics NLP for Electronic Health Records
2 2 Linguamatics 2013 Click Agenda to to edit edit Master Master title style title style Linguamatics and I2E Overview Customer case studies Application examples I2E Demonstration
3 Click Linguamatics to to edit edit Master Master Overview title style title style Formed in 2003 Based on technology developed at SRI, which also produced Apple Siri Leader in text mining/nlp in Life Sciences Pharmaceuticals: 16 of top 20 at every stage of drug discovery Government institutions: Workin with the FDA and divisions of the NIH Leading Healthcare Institutions in a variety of applications 40-50% growth year on year 3 Linguamatics 2013
4 4 Linguamatics 2013 Click EHRs: to to edit A edit Vital Master Master Opportunity title style title style to Improve Patient Care Not for profit Approvers Funders Payers Prescribers ICT The challenge is to unlock the value of the huge investment being made in EHRs Education Electronic Health Record Medical devices Government Providers Research Patient Dispensers In order to arrive at the depth of understanding Biotech they need from analytics, healthcare organizations will need to integrate unstructured data Pharma IDC Health Industry Insights
5 @Linguamatics 2013 Click Most to to people edit edit Master Master familiar title style title with style searching key terms Breast Cancer All these documents contain the keywords breast cancer. Read ALL the document to find the relevant bit to you
6 Efficient review, without reading every 2013 Click Text to Mining to edit edit Master Master Approach title style title style All human genes, and all ways of referring to each gene Any relationship between genes and diseases All Classes of Breast Cancer NLP uses the grammar within the sentence to extract precise results Use of terminologies, clustered results based on preferred terms
7 Click Linguamatics, to to edit edit Master Master Transforming title style title styletext into Patient Insights Turn this Into this To drive these Data warehouse Analytics Accurate results small focussed results set Complete results comprehensive and systematic 8 Linguamatics 2013 Company Confidential
8 9 Linguamatics 2013 Company Confidential Click Introduction to to edit edit Master Master to title Natural style title Language style Processing Groups words into meaningful units Morphology allows search for different forms of words sentences noun phrases verb groups morphology - match entities match actions different forms We find that p42mapk phosphorylates c-myb on serine and threonine. Purified recombinant p42 MAPK was found to phosphorylate Wee1.
9 11 Linguamatics 2013 Company Confidential Click Linguamatics to to edit edit Master Master I2E title style title style Decision Support Structured Results (Actionable Information) Agile NLP Querying Actionable Information Ad hoc queries Smart queries Multi queries Batch queries NLP Class, concept Reg exp Disambiguation Indexing Domain Knowledge Documents Flexible, Highly Scalable Rich Indexes Domain knowledge ontologies, thesauri, coding standards Internal/External Sources
10 @Linguamatics 2013 Click I2E is to to used edit edit Master in Master a title variety style title of style applications Vocabulary Development Gene Profiling Target Identification & Prioritization Safety/Tox Sentiment Analysis in Social Media Mining FDA Drug In the Labels beginning... Competitive IntelligenceProtein- Protein Interactions Workflow Integration Conference Abstract Mining Key Opinion Leader Identification Biomarker Discovery Mining Electronic Medical Records Clinical Trial Analysis Mutations and Gene Expression In-licensing Opportunities Patent Analysis Extracting Numerical and Experimental Data Systems Biology Drug Repositioning
11 13 Linguamatics 2013 Company Confidential Customer Case Studies
12 14 Linguamatics 2013 Confidential Click Linguamatics to to edit edit Master Master Healthcare title style title style Use Cases Pathology, radiology, initial assessment, discharge, check up Structured data Patient characteristics FDA Drug labels Patient characteristics Electronic Health Record Enterprise Data Warehouse Potential adverse drug reactions Patient characteristics Scientific literature Clinical case histories and/or genomic interpretation Patient characteristics Care gap models Patient lists Matching Clinical trials Clinical Trials. gov
13 15 Linguamatics 2013 Huntsman Cancer Institute: Click to to edit edit Master Master title style Turning Pathology Reports title style into Structured Data Challenge Solution Benefit Valuable patient data and insights about malignant tumours trapped in pathology reports, prohibit use in medical research and clinical trial selection Linguamatics I2E used to automatically identify and extract tumour facts from text, using advanced NLP capabilities and medical ontologies Pathology data now systematically extracted from pathology reports and loaded into data warehouse for improved medical research
14 16 Linguamatics 2013 Payer/Provider: Click to to edit edit Master Master title style Predicting Pneumonia title from style Radiology Reports Challenge Solution Benefit Diagnosis of pneumonia is a complex procedure requiring assessment of detailed radiologist s reports In collaboration with Linguamatics and I2E, this Payer/Provider has constructed a model that predicts pneumonia s presence or absence at 93% accuracy More guided diagnosis is allowing radiologists to focus on the uncertain cases and enables faster treatment and reduced risk of side effects
15 Georgetown University: Click to to edit edit Master Master title style Real-time Clinical Decision title style Support Using ipads Challenge Solution Benefit 17 Published literature provides valuable insights into disease comorbidity and treatments from past case histories. These are complex questions that can not be easily answered, causing delays in treatment decisions Linguamatics 2013 Georgetown University and Linguamatics have developed an application that enables rapid identification of case histories from PubMed during hospital rounds This rapid access to relevant data can save days and allows faster decisions to be made, leading to improved patient outcomes
16 18 Copyright Linguamatics 2013 Company Confidential Cardiovascular Disease: Nuclear Stress Test Assessment Click to to edit edit Master Master title style title style Challenge Solution Benefit Nuclear stress tests are a standard part of cardiovascular pathways but may be overlooked resulting in higher patient risk and lost re-imbursement Linguamatics are jointly developing a solution that automatically identifies patients that should be tested based on risk factors identified in their notes Cardiovascular patients are properly monitored, risks identified early and hospitals are reimbursed
17 20 Copyright Linguamatics 2013 Company Confidential Application Examples
18 Click Multiple to to edit edit Ways Master Master title of Interacting style title style Knowledge extraction Patient profile Specific parameters Tumour size, change in size, etc Full extraction Aspiration score (cytology), Peripheral blood smear, Reticulin fibrosis, Diagnosis, Core biopsy, Immunochemistry strain, Cytogenetic, Stain, Symptoms, Chemotherapy, Patient history queries Join to other systems EHR to adverse events EHR to clinical trials 21 Linguamatics 2013
19 22 Copyright Linguamatics 2013 Company Confidential Click Profiling to to edit edit Patients Master Master title from style title Doctors style Notes Collect pieces of information from the records for the patient across discharge summaries, consultations, radiology reports etc. Present as a summary with links to the evidence within the documents themselves for fast access to relevant information
20 Click Making to to edit edit Precise Master Master title Distinctions style title style for Mining and Coding Distinguish family history of disease/history of disease Distinguish history of disease/no history/family history Copyright Linguamatics 2013 Company Confidential 23
21 24 Copyright Linguamatics 2013 Company Confidential Click to edit Master title style Click Change to edit from Master Previous title styleobservation Multiple linguistic constructs Developed vocabulary list of terms to consider
22 25 Copyright Linguamatics 2013 Company Confidential Click to edit Master title style Click Extract to edit Dimensions Master title style in Context Extracted multiple dimensions and different units in same statement
23 26 Copyright Linguamatics 2013 Company Confidential Click to to edit edit Master Master title style title style Match Patients to Relevant Clinical Trials Find conditions of patients Link patients with the condition to appropriate trials Extract inclusion and exclusion conditions Patient Record Information Clinical Trial Information
24 27 Copyright Linguamatics 2013 Company Confidential Click Identify to to edit Potential edit Master Master title Adverse style title Events style Mine EHRs to identify condition and treatment combinations Identify patients with conditions that are known side effects of the drugs they are taking, based on contraindications in FDA label data e.g. rhinitis and dyspnea
25 28 Copyright Linguamatics 2013 Company Confidential Click Identifying to to edit edit Master Potential Master title Safety style title Issues style Compound Potential safety issues In this organ At this dosage
26 Click Translational to to edit edit Master Master Medicine title style title style Connect the patient condition to known information interpretation of sequencing results from research literature genes and known mutations find known adverse events, issues with co-medication 29 Copyright Linguamatics 2013 Company Confidential
27 30 Copyright Linguamatics 2013 Company Confidential Click to to edit edit Master Master title style title style Identify Alternate Treatments, Off Label Uses Discover indirect associations across disease, genes and drug interactions
28 31 Copyright Linguamatics 2013 Company Confidential I2E Demonstration
Flexible NLP for Varied Applications and Data Sources. David Milward, PhD CTO, Linguamatics
Flexible NLP for Varied Applications and Data Sources David Milward, PhD CTO, Linguamatics Overview Using NLP to find, normalize and summarize information Applications: bench to bedside genotype-phenotype
More informationSemantic Enrichment and the Information Manager
WHITEPAPER Semantic Enrichment and the Information Manager Turning Content into Insight It is more resource intensive to bring a drug to market than ever before: Pharmaceutical companies spend an average
More informationNew Frontiers in Personalized Medicine
New Frontiers in Personalized Medicine Oracle Open World Shanghai 2013 Neil de Crescenzo SVP and GM 1 Safe Harbor Statement The following is intended to outline our general product direction. It is intended
More informationAnalytics in Healthcare. Preparing for advance healthcare analytics
Analytics in Healthcare Preparing for advance healthcare analytics Connected Health From devices to data to patients and caregivers through to data analysis that addresses actionable insight, you need
More informationPolicy and Procedure Manual
Policy and Procedure Manual Information Management Medical Records IM-MR-06.21 SUBJECT/TITLE: PURPOSE: DEFINITIONS: DOCUMENTATION OF PATIENT PARTICIPATION AS A SUBJECT IN A RESEARCH PROTOCOL OR USE OF
More informationPersonalized Medicine
Personalized Medicine Dr. Pablo Mentzinis, Director Government Relations, SAP SE Courtesy by Dominik Bertram, Marc von der Linden, Péter Adorján, SAP June 2016 1. Traditional medicine vs. personalized
More informationBig Data & Clinical Informatics
Big Data & Clinical Informatics Client Overview A leading clinical intelligence company that powers healthcare providers, life sciences and research organizations to make better-informed, more confident
More informationIs Your Healthcare Analytics System Missing the Gold in Your EHRs? A Special Report for Healthcare Executives
Is Your Healthcare Analytics System Missing the Gold in Your EHRs? A Special Report for Healthcare Executives Contents Executive Summary 3 Checklist: Are You Mining All the Gold in Your EHRs? 4 What s
More informationWhere are your medical records?
Where are your medical records? Abstract The world of medicine is changing rapidly. We are at the beginning of an era where we treat a patient for their particular condition and not just a general condition.
More informationSNOMED CT in the Age of Precision Medicine
SNOMED CT in the Age of Precision Medicine Charles Gutteridge, Clinical Engagement Lead EMEA, SNOMED International @ gutteridgec HOW DO HUMANS ACT? 31414400 16064300 230063004 Dr Charles Gutteridge Clinical
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationMaximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS
Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS by Jan Nielsen, division president, Access & Patient Support Are You Asking the Right Questions? We ve all
More informationWorking with Health IT Systems is available under a Creative Commons Attribution-NonCommercial- ShareAlike 3.0 Unported license.
Working with Health IT Systems is available under a Creative Commons Attribution-NonCommercial- ShareAlike 3.0 Unported license. Johns Hopkins University. Welcome to Health Management Information Systems,
More informationBig Data The Big Story
Big Data The Big Story Jean-Pierre Dijcks Big Data Product Mangement 1 Agenda What is Big Data? Architecting Big Data Building Big Data Solutions Oracle Big Data Appliance and Big Data Connectors Customer
More informationYASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA.
YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA wns wns ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN
More informationSmart India Hackathon
TM Persistent and Hackathons Smart India Hackathon 2017 i4c www.i4c.co.in Digital Transformation 25% of India between age of 16-25 Our country needs audacious digital transformation to reach its potential
More informationStrategies to increase profitability in Hospitals
.. Strategies to increase profitability in Hospitals Dipl. Betriebswirt Heinz Jörg Schwarz, MS IS Global Business Development Director Regional Health, AGFA HealthCare, Mortsel, Belgium Sr. Adjunct Professor,
More informationTransformational Data-Driven Solutions for Healthcare
Transformational Data-Driven Solutions for Healthcare Transformational Data-Driven Solutions for Healthcare Today s healthcare providers face increasing pressure to improve operational performance while
More informationTargeted Drug Discovery through Data Mining. Copyright 2000 SAS EMEA
Targeted Drug Discovery through Data Mining John Brocklebank, PhD Development Director for Enterprise Miner Wayne Thompson, PhD Product Strategist Data Mining Introduction! This presentation will provide
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationThe importance of regulatory science in a societal and industrial perspective Annual Conference CORS 24 November 2016
The importance of regulatory science in a societal and industrial perspective Annual Conference CORS 24 November 2016 Marianne Kock, Head of Global Regulatory Affairs & Managing Director, Ferring Pharmaceuticals
More informationACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes
ACCELERATING GENOMIC ANALYSIS ON THE CLOUD Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia
More informationE2ES to Accelerate Next-Generation Genome Analysis in Clinical Research
www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution
More informationVolunteering for Clinical Trials
Volunteering for Clinical Trials Volunteering for Clinical Trials When considering volunteering for a clinical trial, it is important to make an informed decision. Below are answers to frequently asked
More informationDESIGN OF COPD BIGDATA HEALTHCARE SYSTEM THROUGH MEDICAL IMAGE ANALYSIS USING IMAGE PROCESSING TECHNIQUES
DESIGN OF COPD BIGDATA HEALTHCARE SYSTEM THROUGH MEDICAL IMAGE ANALYSIS USING IMAGE PROCESSING TECHNIQUES B.Srinivas Raja 1, Ch.Chandrasekhar Reddy 2 1 Research Scholar, Department of ECE, Acharya Nagarjuna
More informationDana-Farber Cancer Institute Speeds Medical Research with Advanced Data Warehouse
Dana-Farber Cancer Institute Speeds Medical Research with Advanced Data Warehouse Dana-Farber Cancer Institute Boston, MA www.dana-farber.org Industry: Healthcare Annual Revenue: US$665.7 million Employees:
More informationThe Perfect Storm: CE and IT Convergence without Collaboration
The Perfect Storm: CE and IT Convergence without Collaboration John Glaser, PhD Vice President and CIO Partners HealthCare April 4, 2009 It was an Unprecedented Set of Circumstances (Bob Case, NOAA) The
More informationDENOMINATOR: All final reports for patients, regardless of age, undergoing a CT procedure
Quality ID #363: Optimizing Patient Exposure to Ionizing Radiation: Search for Prior Computed Tomography (CT) Studies Through a Secure, Authorized, Media-Free, Shared Archive National Quality Strategy
More informationDelivering on the promise: the clinical application of new diagnoses and treatments for RD K A T E B U S H B Y N E W C A S T L E U N I V E R S I T Y
Delivering on the promise: the clinical application of new diagnoses and treatments for RD K A T E B U S H B Y N E W C A S T L E U N I V E R S I T Y PERSPECTIVE/ DISCLAIMERS Doctor with >24 years experience
More informationThe Four Eras of Analytics. Thomas H. Davenport
SESSION #2 The Four Eras of Analytics Thomas H. Davenport Babson/MIT/Deloitte/International Institute for Analytics Four Eras of Analytics Thomas H. Davenport Babson/MIT/Deloitte/International Institute
More informationSEMANTIC DATA PLATFORM FOR HEALTHCARE. Dr. Philipp Daumke
SEMANTIC DATA PLATFORM FOR HEALTHCARE Dr. Philipp Daumke ABOUT AVERBIS Founded: 2007 Location: Team: Focus: Current Sectors: Freiburg, Germany Domain & IT-Experts Leverage structured & unstructured information
More informationLIAISON ALLOY HEALTH PLATFORM
PRODUCT OVERVIEW LIAISON ALLOY HEALTH PLATFORM WELCOME TO YOUR DATA-INSPIRED FUTURE THE LIAISON ALLOY HEALTH PLATFORM Healthcare and life sciences organizations are struggling to deal with unprecedented
More informationEHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES. Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium
EHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium Electronic Health Records for Clinical Research Re-use of EHR data for optimizing Clinical
More informationThe Future of HealthCare Information Technology
HST.921 / HST.922 Information Technology in the Health Care System of the Future, Spring 2009 Harvard-MIT Division of Health Sciences and Technology Course Directors: Dr. Steven Locke, Dr. Bryan Bergeron,
More informationKnowledge Mapping Analysis on Text Mining Research of Medicine Related Fields in Different Regions
Cross-Cultural Communication Vol. 13, No. 9, 2017, pp. 1-9 DOI:10.3968/10006 ISSN 1712-8358[Print] ISSN 1923-6700[Online] www.cscanada.net www.cscanada.org Knowledge Mapping Analysis on Text Mining Research
More informationPharma R&D and Patents support Health Care & Economy
Pharma R&D and Patents support Health Care & Economy Konstantinos Μ. Frouzis President of SFEE, V.P & Gen. Manager of Novartis Hellas April 28 th, 2014 Intellectual Property Patents: The vehicle for innovation
More informationTHE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION
THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices
More informationEnterprise Data An Untapped Asset for Succeeding as Healthcare Changes
Enterprise Data An Untapped Asset for Succeeding as Healthcare Changes 1 2014 Encore, A Quintiles Company. No unauthorized copying or distribution permitted. What We ll Cover It s all about the data Why
More informationDefining Clinical Benefit in Clinical Trials: FDA Perspective
Defining Clinical Benefit in Clinical Trials: FDA Perspective Jessica J. Lee, MD, MMSc Medical Team Leader Division of Gastroenterology and Inborn Errors Products Center for Drug Evaluation and Research
More informationAll-in-One. Oncology EHR Chemotherapy Management Practice Management Revenue Cycle Management
All-in-One Oncology EHR Chemotherapy Management Practice Management Revenue Cycle Management All-in-One CureMD is the leading provider of innovative health information management solutions that transform
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics Dr. Taysir Hassan Abdel Hamid Lecturer, Information Systems Department Faculty of Computer and Information Assiut University taysirhs@aun.edu.eg taysir_soliman@hotmail.com
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce
More informationAPIXIO HCC PROFILER Reimagining Risk Adjustment
APIXIO HCC PROFILER Reimagining Risk Adjustment Traditional Risk Adjustment Methods Aren t Enough Traditionally, risk adjustment has used manual, low-tech methods of identifying, obtaining, and individually
More informationWHITE PAPER. Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs
Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs 1 Executive Summary In today s complex healthcare landscape, the success or failure of a new therapeutic intervention depends
More informationEMEA/AD/258: Head of Sector Pharmacovigilance and Risk Management of Medicinal Products for Human Use (AD9).
EMEA/AD/258: Head of Sector Pharmacovigilance and Risk Management of Medicinal Products for Human Use (AD9). Responsible, under the Head of Unit for the Post-Authorisation Evaluation of Medicinal Products
More informationAutomated Coding Software:
Automated Coding Software: Development and Use to Enhance Anti Fraud Activities Contract Number: HHSP23320054100EC July 11, 2005 Submitted by: Foundation of Research and Education American Health Information
More informationPredictive analytics [Page 105]
Week 8, Lecture 17 and Lecture 18 Predictive analytics [Page 105] Predictive analytics is a highly computational data-mining technology that uses information and business intelligence to build a predictive
More informationKnowledgeSTUDIO. Advanced Modeling for Better Decisions. Data Preparation, Data Profiling and Exploration
KnowledgeSTUDIO Advanced Modeling for Better Decisions Companies that compete with analytics are looking for advanced analytical technologies that accelerate decision making and identify opportunities
More informationKonica Minolta to Acquire Invicro (US)
Konica Minolta to Acquire Invicro (US) Acceleration of expansion of precision medicine business Offering new value for drug discovery and development in immuno-oncology and neurodegenerative disease September
More informationChristoph Bock ICPerMed First Research Workshop Milano, 26 June 2017
New Tools for Personalized Medicine *Tools = Assays, Devices, Software Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 http://epigenomics.cemm.oeaw.ac.at http://biomedical-sequencing.at
More informationCentricity * Precision Reporting
GE Healthcare Centricity * Precision Reporting A more intelligent approach to diagnostic reporting. Healthcare IT Re-Imagined 1 1 1 0 0 1 0 1 0 0 0 0 *Trademark of General Electric Company. Imagine being
More informationPharmacogenomics, Market Opportunities and Barriers. Presenter: Patrick J. Hurd, Esq. Senior Counsel Moderator: James P. Anelli, Esq.
, Market Opportunities and Barriers Presenter: Patrick J. Hurd, Esq. Senior Counsel Moderator: James P. Anelli, Esq. Shareholder January 13, 2011 Today s presenters and some notes... Jim Anelli LeClairRyan
More informationCENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
CENTRAL NERVOUS SYSTEM (CNS) : TECHNOLOGIES AND GLOBAL MARKETS BIO074C March 2016 Jackson Highsmith Project Analyst ISBN: 1-62296-246-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationNew WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research
New WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research Hanne Bak Pedersen Programme Manager Health Technologies and Pharmaceuticals
More informationTranslational Research through Public-Private Partnerships. 65 th Annual Bohan Lecture. Scott J. Weir, PharmD, PhD 08 October 2011
Translational Research through Public-Private Partnerships 65 th Annual Bohan Lecture Scott J. Weir, PharmD, PhD 08 October 2011 Drug Focused Translational Research Translational Research Defined by the
More informationThe Pathways to Understanding Diseases
FOR PHARMA & LIFE SCIENCES White paper The Pathways to Understanding Diseases Deciphering complex biological processes Executive Summary Understanding complex biological processes is critical whether doing
More informationSummary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015
Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the
More informationataluren overview A New Approach to Genetic Disorders
ataluren overview A New Approach to Genetic Disorders Ataluren Scientific Background What is ataluren? Ataluren(formerly PTC124) is the first investigational therapy with the potential to enable the formation
More informationEMR, its relevance, its benefits and options available. Dr.R.R.Sudhir Head of Dept of Preventive Ophthalmology Sankara Nethralaya Chennai
EMR, its relevance, its benefits and options available Dr.R.R.Sudhir Head of Dept of Preventive Ophthalmology Sankara Nethralaya Chennai Introduction The ideal of health care in the information age must
More informationOptum Performance Analytics
Optum Performance Analytics A unified health care data and analytics platform Photo to come Optum Performance Analytics Position your organization for success with Optum Performance Analytics Dynamic health
More informationTranslational Research
Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic
More informationRegulatory Challenges of Global Drug Development in Oncology. Jurij Petrin, M.D. Princeton, NJ
Regulatory Challenges of Global Drug Development in Oncology Jurij Petrin, M.D. Princeton, NJ Topics General global R&D issues Regulatory issues with global oncology drug development US FDA initiatives
More informationInbound Material Transfer Agreement Questionnaire
This form is to be used when requesting materials using a Material Transfer Agreement (MTA). The information you provide will aid in reviewing the agreement. KU RECIPIENT SCIENTIST S INFORMATION Inbound
More informationThe NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England
The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.
More informationOptum Labs: A Center for Collaborative Healthcare Research and Innovation
Optum Labs: A Center for Collaborative Healthcare Research and Innovation Paul Bleicher, MD PhD CEO, Optum Labs October 16, 2013 What s Missing in Healthcare Research and Innovation? Collaboration across
More informationIntegrating Genomics in Family Medicine
Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Integrating Genomics in Family Medicine Brian Stello MD Lehigh Valley Health Network, Brian.Stello@lvhn.org Follow this and
More informationThe Innovative Medicines Initiative Socio-economic impacts
The Innovative Medicines Initiative Socio-economic impacts Pierre Meulien, IMI Executive Director European Innovation Summit European Parliament 08.12.2015 Closed & open innovation Filing Approval HTA
More informationDeveloping an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL
Developing an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL James Storhoff, Ph.D. Senior Manager, Diagnostic Test Development World Cdx, Boston, Sep. 10th Molecules That
More informationOff-Label Use of FDA-Approved Drugs and Biologicals
Off-Label Use of FDA-Approved Drugs and Biologicals Last Review Date: January 12, 2018 Number: MG.MM.AD.06cC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician
More informationMcKinsey Center for Government What's Driving the Recent Surge in New Drug Approvals?
McKinsey Center for Government What's Driving the Recent Surge in New Drug Approvals? Alexia Cesar, Philip Ma, Navjot Singh, Jeff Smith What's Driving the Recent Surge in New Drug Approvals? In 2012, the
More informationPresentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development
Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International
More informationHealthcare Solutions Nuance PowerShare Network. PowerShare. The industry s largest medical imaging network.
PowerShare. The industry s largest medical imaging network. 2 Easily find other providers and begin sharing in minutes. The Nuance PowerShare Network connects healthcare facilities, providers and patients
More informationReal World Evidence Transforming patient care
Real World Evidence Transforming patient care 1 6 8 3 In scarcely an instance have I been able to obtain hospital records fit for any purpose of comparison if wisely used [hospital records] could tell
More informationMEDHOST Emergency Department Information System
EDIS includes intuitive, graphical floor plans of your ED that enhance staff communication and workflow. MEDHOST Emergency Department Information System Emergency departments are the front door to America
More informationUniversity Of Pathology Informatics Certificate Of Completion Program
University Of Pathology Informatics Certificate Of Completion Program Course Program Syllabus Courses for Completion: 20 Type of Instruction: Online (and Blended where applicable) Administrative Notes
More informationGenentech, Inc., its research partners, collaborators, assignees, licensees or designees. Invitation to Participate
CONSENT AND RESEARCH AUTHORIZATION TO DONATE BLOOD AND TISSUE SAMPLES FOR FUTURE RESEARCH PURPOSES YALE UNIVERSITY SCHOOL OF MEDICINE YALE-NEW HAVEN HOSPITAL 200 FR. 4 Study Title: An Open-Label, Phase
More informationCritical Path to TB Drug Regimens (CPTR)
Critical Path to TB Drug Regimens (CPTR) Why do we need a CPTR initiative? We finally have a pipeline of TB drug candidates Today, we test drugs same way we did 20 years ago Need better tests for drug
More informationGenomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)
Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome
More informationDevices, Big Data, and Real World Evidence O R A C L E W H I T E P A P E R O C T O B E R
Devices, Big Data, and Real World Evidence O R A C L E W H I T E P A P E R O C T O B E R 2 0 1 7 Disclaimer The following is intended to outline our general product direction. It is intended for information
More informationPreanalytical Variables in Blood Collection: Impact on Precision Medicine
Preanalytical Variables in Blood Collection: Impact on Precision Medicine Carolyn Compton, MD, PhD Chair, Scientific Advisory Committee, Indivumed GmbH Professor of Life Sciences, ASU Professor of Laboratory
More informationThe Innovative Medicines Initiative: Building new models of collaborative research across Europe
The Innovative Medicines Initiative: Building new models of collaborative research across Europe Elisabetta Vaudano IMI, Belgium www.imi.europa.eu What is IMI? An European Public-Private Partnership Focused
More informationNonproprietary Naming of Biological Products; Draft Guidance for Industry; Docket No. FDA 2013 D 1543 October 27, 2015
Electronic Submission via http://www.regulations.gov Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, Maryland 20852 Re: Nonproprietary Naming
More informationBob Picciano Senior Vice President IBM ANALYTICS International Business Machines Corporation
Bob Picciano Senior Vice President IBM ANALYTICS 2015 International Business Machines Corporation 1 Forward-Looking Statement Certain comments made during this event and in the presentation materials may
More informationWhite paper The Polish pharmaceutical market has undergone many changes as a result of the new Reimbursement Act
White paper The Polish pharmaceutical market has undergone many changes as a result of the new Reimbursement Act Published: July 2014 Author: Anantharaman Kavassery Viswanthan Anantharaman Kavassery Viswanathan
More information"From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia
"From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia Damir Hamamdžić D.V.M., Ph.D. Office of Research Regulatory Affairs Rutgers University RWJMS
More informationGENERAL PAYER CONSIDERATIONS FOR NEW HEALTH TECHNOLOGIES (INCLUDING DIAGNOSTICS)
FORUM Payer perspectives and actions impacting diagnostics in the US and Europe Eric Faulkner, MPH Director, Quintiles Global Market Access Consulting; Executive Director, Genomics Biotech Emerging Medical
More informationEU support for Health Research from FP6 to FP7
EU support for Health Research from FP6 to FP7 Stéphane Hogan Head of Biotechnology Unit Directorate for Health Research DG Research - European Commission Valencia - 15 September 2006 EU research programmes
More informationHackensack University Medical Center
CUSTOMER INNOVATION STUDY Hackensack University Medical Center gets one step closer to precision medicine with cloud-based Infor Cloverleaf Integration Suite We are trying to understand human beings. So
More informationTitle: Department: Approved by: Director, Human Research Review and Compliance
Title: Department: Requirements for Investigational New Drug (IND) for Human- Subjects Research Human Research Affairs Policy Type: Partners System-wide Partners System-wide Template Partners HealthCare
More informationUniversità Cattolica del Sacro Cuore
Università Cattolica del Sacro Cuore The role of Regulatory Affairs in drug development Francesco Mazza, Director of Legal, Fiscal & Compliance Affairs in Farmindustria Rome, May 12 2017 Who we are Who
More informationProduct Applications for the Sequence Analysis Collection
Product Applications for the Sequence Analysis Collection Pipeline Pilot Contents Introduction... 1 Pipeline Pilot and Bioinformatics... 2 Sequence Searching with Profile HMM...2 Integrating Data in a
More informationTeradata Next-Generation Healthcare Analytics
Teradata Next-Generation Healthcare Analytics Nov 25 th, 2016 Ozgur Kaynar Senior Business Consultant ozgur.kaynar@teradata.com 1 Agenda Healthcare Trends & Challenges Teradata Approach to Healthcare Teradata
More informationFDA Public Hearing: Approval Pathway for Biosimilar. Products. November 2-3, 2010
FDA Public Hearing: Approval Pathway for Biosimilar and Interchangeable Biological Products November 2-3, 2010 1 The Biotechnology Industry Organization Over 1,100 members, including biotechnology companies,
More informationTechnology Trends and Impacts on CDI Programs. Tim Minnich, Solution Sales Executive, Mobile:
Technology Trends and Impacts on CDI Programs Tim Minnich, Solution Sales Executive, Tim.minnich@optum.com Mobile: 610-587-7366 Computer Assisted Coding & NLP The use of computer software that automatically
More informationDisclaimer. 2
www.valirx.com 1 Disclaimer This Document comprises an institutional presentation (the Presentation ) which has been prepared by and is the sole responsibility of ValiRx plc (the Company ). The content
More informationHealth Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center
Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Dave Bode VP, Health Care Solutions DSC Logistics April 20, 2016 Health
More informationDeveloping a "Cookbook" of Reports & Visualizations for Drug Target CI
BizInt Smart Charts 2014 1 Developing a "Cookbook" of Reports & Visualizations for Drug Target CI February 18, 2014 Pharma CI Europe, Barcelona Diane Webb, President, BizInt Solutions John Willmore, VP,
More information